LSR takeover by CEO gets board OK
Andrew Baker, the chairman and CEO of Life Sciences Research, an East Millstone, New Jersey, contract research organization, has obtained "a definitive agreement" to acquire the firm for $8.50 per share in cash.
Archives for July 14, 2009
Gerresheimer cuts forecast despite pharma packaging growth
Gerresheimer has cut its forecast for 2009 after a poor second quarter that saw gains made in drug packaging pegged back by falling demand from the cosmetics industry.
Pfizer plans 10-fold increase in cancer drug sales
US drug giant Pfizer wants a massive increase in sales of cancer drugs by 2018 to sustain growth.
Oscient files for bankruptcy and sells Factive
US drugmaker Oscient Pharmaceuticals has filed for chapter 11 bankruptcy and will sell its bronchitis therapy Factive (gemifloxacin mesylate) to North Carolina-based Cornerstone Therapeutics for $5m (€3.5m).
Chiltern posts positive annual results with 44% rise in revenue
UK CRO Chiltern International announced positive financial results for the year ending March 2009, possibly suggesting a bounce for a sector that has been hit by project cancellations.
Johnson and Johnson sales hit by tough retail environment
Leading pharmaceutical and personal care player Johnson & Johnson has been hit hard during its second quarter by the global economic recession.